[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Sykehuset i Vestfold HF\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":64},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100552113","glucose-monitoring-in-treatment-of-postprandial-hypoglycemia-after-gastric-bypass-surgery-100552113",false,"NCT06468865","Glucose Monitoring in Treatment of Postprandial Hypoglycemia After Gastric Bypass Surgery","Continuous Glucose Monitoring in Treatment of Postprandial Hypoglycemia After Gastric Bypass Surgery: The HypoSurge Randomized Clinical Trial","HypoSurge","Inclusion Criteria:\n\n* Gastric bypass surgery at least 1 year ago\n* Age ≥18 years\n* Symptomatic postprandial hypoglycaemia; capillary glucose level \\\u003C3.0 mmol\u002FL 1-4 hours after meals\n\nExclusion Criteria:\n\n* Not able to give informed consent\n* Reduced compliance due to severe mental and psychiatric conditions\n* Use of insulin or sulfonylureas\n* Use of systemic corticosteroids\n* Primary or secondary adrenal insufficiency\n* Insulinoma\n* Severe heart-, lung, liver- or kidney disease, cancer, malnutrition and other medical conditions causing fragility\n* Performed bariatric revisional surgery\n* Drug- or alcohol abuse\n* Pregnancy\n* Use of acarbose or octreotide in the treatment of postprandial hypoglycemia\n* Use of continuous glucose monitor",true,"ALL","18 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to learn if continuous glucose monitoring works to treat postprandial hypoglycaemia in patients who have undergone gastric bypass surgery. The main question it aims to answer is:\n\n• Is continuous glucose monitoring superior to usual care for prevention of postprandial hypoglycaemia in patients with verified postprandial hypoglycaemia after gastric bypass surgery?\n\nResearchers will compare continuous glucose monitoring to usual care to see if continuous glucose monitoring works to treat postprandial hypoglycaemia.\n\nParticipants will:\n\n* Use a continuous glucose monitor for 6 weeks or use no continuous glucose monitor for 5 weeks and wear a blinded continuous glucose monitor for 1 week.\n* Visit the clinic 2-3 times and have 2-3 phone consultations.\n* Register symptoms of hypoglycaemia, answer questionnaires, undergo a 24-hour dietary recall interview conducted by a registered dietitian, measure weight and body composition and take blood samples.",[28,29],"Hypoglycemia Non-Diabetic","Gastric Bypass Surgery","RECRUITING","2024-11-01",{"date":33,"type":34},"2024-11-05","ACTUAL",{"date":36,"type":22},"2024-11-12",{"date":38,"type":22},"2026-12-31",{"name":40,"class":41},"Sykehuset i Vestfold HF","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":23,"phases":52,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":63,"locationsCount":42},"100505200","hjernegym---effects-of-exergaming-in-psychosis-a-clinical-intervention-study-100505200","NCT05858255","Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study","Inclusion Criteria:\n\n* Having consent capability\n* Understanding and speaking Scandinavian language\n* Fulfilling the International Classification of Diseases Tenth Revision (ICD 10) criteria for schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder and schizophreniform disorder)\n\nExclusion Criteria:\n\n* Diagnosis of intellectual disability\n* Diagnosis of neurological disorder\n* History of severe head trauma\n* Pregnancy\n* Chest pain during exercise\n* Unstable angina pectoris\n* Malignant hypertension\n* Uncontrollable arrhythmia\n* Recent myocardial infarction\n* Acute infection with lymphadenopathy\n* Other specified medical condition incompatible with participation","65 Years",{"count":51,"type":22},48,[25],"The goal of this clinical intervention study is to investigate the effects of exergaming on cognition and other clinical symptoms in outpatient individuals with schizophrenia.\n\nThe main questions it aims to answer are: Will an exergaming intervention contribute to improved cognition and reduced clinical symptoms, as well as enhanced physical health\u002Fself-efficacy\u002Fquality of life, in individuals with schizophrenia? Will the gaming component strengthen motivation for a physically more intensive component, so that attendance will be at least as high as in comparable exercise studies despite the current study being implemented in a resource-limited, regular clinical outpatient setting? Participants will be asked to engage in two 45 minutes exergaming sessions with a designated personal trainer for 12 weeks. Results pre- and post intervention will be compared, and comparisons will also be made with a former randomized controlled trial conducted at the same site, in which the currently combined activities were investigated separately (high-intensity interval training and low-intensity video gaming), both yielding positive but different effects.",[55,56],"Schizophrenia; Psychosis","Cognitive Impairment","2023-05-04",{"date":59,"type":34},"2023-05-15",{"date":61,"type":34},"2023-03-29",{"date":38,"type":22},{"name":40,"class":41},""]